Search Orphan Drug Designations and Approvals
-
Generic Name: | humanized monoclonal antibody against human PD-1 |
---|---|
Date Designated: | 06/08/2017 |
Orphan Designation: | Treatment of neuroendocrine tumors |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 02/20/2024 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Novartis Pharmaceuticals Corp. One Health Plaza, 315/5450A East Hanover, New Jersey 07936 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-